chr4-118723343-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_014822.4(SEC24D):c.*172A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00271 in 578,128 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0074 ( 7 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 5 hom. )
Consequence
SEC24D
NM_014822.4 3_prime_UTR
NM_014822.4 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.37
Genes affected
SEC24D (HGNC:10706): (SEC24 homolog D, COPII coat complex component) The protein encoded by this gene is a member of the SEC24 subfamily of the SEC23/SEC24 family, which is involved in vesicle trafficking. The encoded protein has similarity to yeast Sec24p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. This gene product is implicated in the shaping of the vesicle, and also in cargo selection and concentration. Mutations in this gene have been associated with Cole-Carpenter syndrome, a disorder affecting bone formation, resulting in craniofacial malformations and bones that break easily. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 4-118723343-T-C is Benign according to our data. Variant chr4-118723343-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 1181948.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00743 (1131/152312) while in subpopulation AFR AF= 0.0253 (1052/41562). AF 95% confidence interval is 0.024. There are 7 homozygotes in gnomad4. There are 541 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 7 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SEC24D | NM_014822.4 | c.*172A>G | 3_prime_UTR_variant | 23/23 | ENST00000280551.11 | ||
SEC24D | NM_001318066.2 | c.*172A>G | 3_prime_UTR_variant | 23/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SEC24D | ENST00000280551.11 | c.*172A>G | 3_prime_UTR_variant | 23/23 | 1 | NM_014822.4 | P1 | ||
SEC24D | ENST00000511481.5 | c.*172A>G | 3_prime_UTR_variant | 16/16 | 1 | ||||
SEC24D | ENST00000505134.5 | n.3402A>G | non_coding_transcript_exon_variant | 18/18 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00741 AC: 1127AN: 152194Hom.: 6 Cov.: 32
GnomAD3 genomes
AF:
AC:
1127
AN:
152194
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00102 AC: 434AN: 425816Hom.: 5 Cov.: 6 AF XY: 0.000932 AC XY: 207AN XY: 222198
GnomAD4 exome
AF:
AC:
434
AN:
425816
Hom.:
Cov.:
6
AF XY:
AC XY:
207
AN XY:
222198
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00743 AC: 1131AN: 152312Hom.: 7 Cov.: 32 AF XY: 0.00726 AC XY: 541AN XY: 74472
GnomAD4 genome
AF:
AC:
1131
AN:
152312
Hom.:
Cov.:
32
AF XY:
AC XY:
541
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
10
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | May 18, 2019 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at